Nash Drugs Market 2022: Key Strategies, Historical Analysis, Trends, New Opportunities and Forecast Till 2028
Nash Drugs Market 2022: Key Strategies, Historical Analysis, Trends, New Opportunities and Forecast Till 2028
Nash Drugs Market by End User (Office Building Construction, Retail Construction, Hospitality Construction, Institutional Construction, Other End Users), by North America (United States, Canada, Mexico), by South America (Brazil, Argentina, Rest of South America), by Europe (United Kingdom, Germany, France, Italy, Spain, Russia, Benelux, Nordics, Rest of Europe), by Middle East & Africa (Turkey, Israel, GCC, North Africa, South Africa, Rest of Middle East & Africa), by Asia Pacific (China, India, Japan, South Korea, ASEAN, Oceania, Rest of Asia Pacific) Forecast - is a comprehensive report that provides insights into the market dynamics, including the key drivers, challenges, and opportunities shaping the industry landscape. It also delves into the competitive landscape, highlighting the major players and their strategies.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Non-alcoholic Steatohepatitis or NASH is a common term for silent liver disease and can result into cirrhosis, in which liver is permanently damaged and after a certain point could lead to death.
This report elaborates the market size, market characteristics, and market growth of the Nash Drugs industry, and breaks down according to the type, application, and consumption area of Nash Drugs. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Nash Drugs in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.
Key players in the global Nash Drugs market covered in Chapter 13:
Galmed Pharmaceuticals
Zydus Cadila
Conatus Pharmaceuticals
Gilead Sciences, Inc.
Novo Nordisk
Genfit SA
Intercept Pharmaceuticals, Inc.
Raptor Pharmaceuticals
Allergan Plc (Tobira)
In Chapter 6, on the basis of types, the Nash Drugs market from 2015 to 2025 is primarily split into:
Vitamin E & Pioglitazone
Ocaliva
Elafibranor
Selonsertib & Cenicriviroc
In Chapter 7, on the basis of applications, the Nash Drugs market from 2015 to 2025 covers:
Hospital Pharmacy
Online Provider
Retail Pharmacy
Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Table of Content
1 Nash Drugs Market - Research Scope
1.1 Study Goals
1.2 Market Definition and Scope
1.3 Key Market Segments
1.4 Study and Forecasting Years
2 Nash Drugs Market - Research Methodology
2.1 Methodology
2.2 Research Data Source
2.2.1 Secondary Data
2.2.2 Primary Data
2.2.3 Market Size Estimation
2.2.4 Legal Disclaimer
3 Nash Drugs Market Forces
3.1 Global Nash Drugs Market Size
3.2 Top Impacting Factors (PESTEL Analysis)
3.2.1 Political Factors
3.2.2 Economic Factors
3.2.3 Social Factors
3.2.4 Technological Factors
3.2.5 Environmental Factors
3.2.6 Legal Factors
3.3 Industry Trend Analysis
3.4 Industry Trends Under COVID-19
3.4.1 Risk Assessment on COVID-19
3.4.2 Assessment of the Overall Impact of COVID-19 on the Industry
3.4.3 Pre COVID-19 and Post COVID-19 Market Scenario
3.5 Industry Risk Assessment
4 Nash Drugs Market - By Geography
4.1 Global Nash Drugs Market Value and Market Share by Regions
4.1.1 Global Nash Drugs Value ($) by Region (2015-2020)
4.1.2 Global Nash Drugs Value Market Share by Regions (2015-2020)
4.2 Global Nash Drugs Market Production and Market Share by Major Countries
4.2.1 Global Nash Drugs Production by Major Countries (2015-2020)
4.2.2 Global Nash Drugs Production Market Share by Major Countries (2015-2020)
4.3 Global Nash Drugs Market Consumption and Market Share by Regions
4.3.1 Global Nash Drugs Consumption by Regions (2015-2020)
4.3.2 Global Nash Drugs Consumption Market Share by Regions (2015-2020)
5 Nash Drugs Market - By Trade Statistics
5.1 Global Nash Drugs Export and Import
5.2 United States Nash Drugs Export and Import (2015-2020)
5.3 Europe Nash Drugs Export and Import (2015-2020)
5.4 China Nash Drugs Export and Import (2015-2020)
5.5 Japan Nash Drugs Export and Import (2015-2020)
5.6 India Nash Drugs Export and Import (2015-2020)
5.7
6 Nash Drugs Market - By Type
6.1 Global Nash Drugs Production and Market Share by Types (2015-2020)
6.1.1 Global Nash Drugs Production by Types (2015-2020)
6.1.2 Global Nash Drugs Production Market Share by Types (2015-2020)
6.2 Global Nash Drugs Value and Market Share by Types (2015-2020)
6.2.1 Global Nash Drugs Value by Types (2015-2020)
6.2.2 Global Nash Drugs Value Market Share by Types (2015-2020)
6.3 Global Nash Drugs Production, Price and Growth Rate of Vitamin E & Pioglitazone (2015-2020)
6.4 Global Nash Drugs Production, Price and Growth Rate of Ocaliva (2015-2020)
6.5 Global Nash Drugs Production, Price and Growth Rate of Elafibranor (2015-2020)
6.6 Global Nash Drugs Production, Price and Growth Rate of Selonsertib & Cenicriviroc (2015-2020)
7 Nash Drugs Market - By Application
7.1 Global Nash Drugs Consumption and Market Share by Applications (2015-2020)
7.1.1 Global Nash Drugs Consumption by Applications (2015-2020)
7.1.2 Global Nash Drugs Consumption Market Share by Applications (2015-2020)
7.2 Global Nash Drugs Consumption and Growth Rate of Hospital Pharmacy (2015-2020)
7.3 Global Nash Drugs Consumption and Growth Rate of Online Provider (2015-2020)
7.4 Global Nash Drugs Consumption and Growth Rate of Retail Pharmacy (2015-2020)
8 North America Nash Drugs Market
8.1 North America Nash Drugs Market Size
8.2 United States Nash Drugs Market Size
8.3 Canada Nash Drugs Market Size
8.4 Mexico Nash Drugs Market Size
8.5 The Influence of COVID-19 on North America Market
9 Europe Nash Drugs Market Analysis
9.1 Europe Nash Drugs Market Size
9.2 Germany Nash Drugs Market Size
9.3 United Kingdom Nash Drugs Market Size
9.4 France Nash Drugs Market Size
9.5 Italy Nash Drugs Market Size
9.6 Spain Nash Drugs Market Size
9.7 The Influence of COVID-19 on Europe Market
10 Asia-Pacific Nash Drugs Market Analysis
10.1 Asia-Pacific Nash Drugs Market Size
10.2 China Nash Drugs Market Size
10.3 Japan Nash Drugs Market Size
10.4 South Korea Nash Drugs Market Size
10.5 Southeast Asia Nash Drugs Market Size
10.6 India Nash Drugs Market Size
10.7 The Influence of COVID-19 on Asia Pacific Market
11 Middle East and Africa Nash Drugs Market Analysis
11.1 Middle East and Africa Nash Drugs Market Size
11.2 Saudi Arabia Nash Drugs Market Size
11.3 UAE Nash Drugs Market Size
11.4 South Africa Nash Drugs Market Size
11.5 The Influence of COVID-19 on Middle East and Africa Market
12 South America Nash Drugs Market Analysis
12.1 South America Nash Drugs Market Size
12.2 Brazil Nash Drugs Market Size
12.3 The Influence of COVID-19 on South America Market
13 Company Profiles
13.1 Galmed Pharmaceuticals
13.1.1 Galmed Pharmaceuticals Basic Information
13.1.2 Galmed Pharmaceuticals Product Profiles, Application and Specification
13.1.3 Galmed Pharmaceuticals Nash Drugs Market Performance (2015-2020)
13.2 Zydus Cadila
13.2.1 Zydus Cadila Basic Information
13.2.2 Zydus Cadila Product Profiles, Application and Specification
13.2.3 Zydus Cadila Nash Drugs Market Performance (2015-2020)
13.3 Conatus Pharmaceuticals
13.3.1 Conatus Pharmaceuticals Basic Information
13.3.2 Conatus Pharmaceuticals Product Profiles, Application and Specification
13.3.3 Conatus Pharmaceuticals Nash Drugs Market Performance (2015-2020)
13.4 Gilead Sciences, Inc.
13.4.1 Gilead Sciences, Inc. Basic Information
13.4.2 Gilead Sciences, Inc. Product Profiles, Application and Specification
13.4.3 Gilead Sciences, Inc. Nash Drugs Market Performance (2015-2020)
13.5 Novo Nordisk
13.5.1 Novo Nordisk Basic Information
13.5.2 Novo Nordisk Product Profiles, Application and Specification
13.5.3 Novo Nordisk Nash Drugs Market Performance (2015-2020)
13.6 Genfit SA
13.6.1 Genfit SA Basic Information
13.6.2 Genfit SA Product Profiles, Application and Specification
13.6.3 Genfit SA Nash Drugs Market Performance (2015-2020)
13.7 Intercept Pharmaceuticals, Inc.
13.7.1 Intercept Pharmaceuticals, Inc. Basic Information
13.7.2 Intercept Pharmaceuticals, Inc. Product Profiles, Application and Specification
13.7.3 Intercept Pharmaceuticals, Inc. Nash Drugs Market Performance (2015-2020)
13.8 Raptor Pharmaceuticals
13.8.1 Raptor Pharmaceuticals Basic Information
13.8.2 Raptor Pharmaceuticals Product Profiles, Application and Specification
13.8.3 Raptor Pharmaceuticals Nash Drugs Market Performance (2015-2020)
13.9 Allergan Plc (Tobira)
13.9.1 Allergan Plc (Tobira) Basic Information
13.9.2 Allergan Plc (Tobira) Product Profiles, Application and Specification
13.9.3 Allergan Plc (Tobira) Nash Drugs Market Performance (2015-2020)
14 Market Forecast - By Regions
14.1 North America Nash Drugs Market Forecast (2020-2025)
14.2 Europe Nash Drugs Market Forecast (2020-2025)
14.3 Asia-Pacific Nash Drugs Market Forecast (2020-2025)
14.4 Middle East and Africa Nash Drugs Market Forecast (2020-2025)
14.5 South America Nash Drugs Market Forecast (2020-2025)
15 Market Forecast - By Type and Applications
15.1 Global Nash Drugs Market Forecast by Types (2020-2025)
15.1.1 Global Nash Drugs Market Forecast Production and Market Share by Types (2020-2025)
15.1.2 Global Nash Drugs Market Forecast Value and Market Share by Types (2020-2025)
15.2 Global Nash Drugs Market Forecast by Applications (2020-2025)
List of Tables and Figures
Figure Nash Drugs Picture
Table Nash Drugs Key Market Segments
Figure Study and Forecasting Years
Figure Global Nash Drugs Market Size and Growth Rate 2015-2025
Figure Industry PESTEL Analysis
Figure Global COVID-19 Status
Figure Market Size Forecast Comparison of Pre COVID-19 and Post COVID-19
Figure Global Nash Drugs Value ($) and Growth Rate (2015-2020)
Table Global Nash Drugs Value ($) by Countries (2015-2020)
Table Global Nash Drugs Value Market Share by Regions (2015-2020)
Figure Global Nash Drugs Value Market Share by Regions in 2019
Figure Global Nash Drugs Production and Growth Rate (2015-2020)
Table Global Nash Drugs Production by Major Countries (2015-2020)
Table Global Nash Drugs Production Market Share by Major Countries (2015-2020)
Figure Global Nash Drugs Production Market Share by Regions in 2019
Figure Global Nash Drugs Consumption and Growth Rate (2015-2020)
Table Global Nash Drugs Consumption by Regions (2015-2020)
Table Global Nash Drugs Consumption Market Share by Regions (2015-2020)
Figure Global Nash Drugs Consumption Market Share by Regions in 2019
Table Global Nash Drugs Export Top 3 Country 2019
Table Global Nash Drugs Import Top 3 Country 2019
Table United States Nash Drugs Export and Import (2015-2020)
Table Europe Nash Drugs Export and Import (2015-2020)
Table China Nash Drugs Export and Import (2015-2020)
Table Japan Nash Drugs Export and Import (2015-2020)
Table India Nash Drugs Export and Import (2015-2020)
Table Global Nash Drugs Production by Types (2015-2020)
Table Global Nash Drugs Production Market Share by Types (2015-2020)
Figure Global Nash Drugs Production Share by Type (2015-2020)
Table Global Nash Drugs Value by Types (2015-2020)
Table Global Nash Drugs Value Market Share by Types (2015-2020)
Figure Global Nash Drugs Value Share by Type (2015-2020)
Figure Global Vitamin E & Pioglitazone Production and Growth Rate (2015-2020)
Figure Global Vitamin E & Pioglitazone Price (2015-2020)
Figure Global Ocaliva Production and Growth Rate (2015-2020)
Figure Global Ocaliva Price (2015-2020)
Figure Global Elafibranor Production and Growth Rate (2015-2020)
Figure Global Elafibranor Price (2015-2020)
Figure Global Selonsertib & Cenicriviroc Production and Growth Rate (2015-2020)
Figure Global Selonsertib & Cenicriviroc Price (2015-2020)
Table Global Nash Drugs Consumption by Applications (2015-2020)
Table Global Nash Drugs Consumption Market Share by Applications (2015-2020)
Figure Global Nash Drugs Consumption Share by Application (2015-2020)
Figure Global Hospital Pharmacy Consumption and Growth Rate (2015-2020)
Figure Global Online Provider Consumption and Growth Rate (2015-2020)
Figure Global Retail Pharmacy Consumption and Growth Rate (2015-2020)
Figure North America Nash Drugs Market Consumption and Growth Rate (2015-2020)
Table North America Nash Drugs Consumption by Countries (2015-2020)
Table North America Nash Drugs Consumption Market Share by Countries (2015-2020)
Figure North America Nash Drugs Consumption Market Share by Countries (2015-2020)
Figure United States Nash Drugs Market Consumption and Growth Rate (2015-2020)
Figure Canada Nash Drugs Market Consumption and Growth Rate (2015-2020)
Figure Mexico Nash Drugs Market Consumption and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure Europe Nash Drugs Market Consumption and Growth Rate (2015-2020)
Table Europe Nash Drugs Consumption by Countries (2015-2020)
Table Europe Nash Drugs Consumption Market Share by Countries (2015-2020)
Figure Europe Nash Drugs Consumption Market Share by Countries (2015-2020)
Figure Germany Nash Drugs Market Consumption and Growth Rate (2015-2020)
Figure United Kingdom Nash Drugs Market Consumption and Growth Rate (2015-2020)
Figure France Nash Drugs Market Consumption and Growth Rate (2015-2020)
Figure Italy Nash Drugs Market Consumption and Growth Rate (2015-2020)
Figure Spain Nash Drugs Market Consumption and Growth Rate (2015-2020)
Figure Europe COVID-19 Status
Figure Asia-Pacific Nash Drugs Market Consumption and Growth Rate (2015-2020)
Table Asia-Pacific Nash Drugs Consumption by Countries (2015-2020)
Table Asia-Pacific Nash Drugs Consumption Market Share by Countries (2015-2020)
Figure Asia-Pacific Nash Drugs Consumption Market Share by Countries (2015-2020)
Figure China Nash Drugs Market Consumption and Growth Rate (2015-2020)
Figure Japan Nash Drugs Market Consumption and Growth Rate (2015-2020)
Figure South Korea Nash Drugs Market Consumption and Growth Rate (2015-2020)
Figure Southeast Asia Nash Drugs Market Consumption and Growth Rate (2015-2020)
Figure India Nash Drugs Market Consumption and Growth Rate (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Middle East and Africa Nash Drugs Market Consumption and Growth Rate (2015-2020)
Table Middle East and Africa Nash Drugs Consumption by Countries (2015-2020)
Table Middle East and Africa Nash Drugs Consumption Market Share by Countries (2015-2020)
Figure Middle East and Africa Nash Drugs Consumption Market Share by Countries (2015-2020)
Figure Saudi Arabia Nash Drugs Market Consumption and Growth Rate (2015-2020)
Figure UAE Nash Drugs Market Consumption and Growth Rate (2015-2020)
Figure South Africa Nash Drugs Market Consumption and Growth Rate (2015-2020)
Figure South America Nash Drugs Market Consumption and Growth Rate (2015-2020)
Table South America Nash Drugs Consumption by Countries (2015-2020)
Table South America Nash Drugs Consumption Market Share by Countries (2015-2020)
Figure South America Nash Drugs Consumption Market Share by Countries (2015-2020)
Figure Brazil Nash Drugs Market Consumption and Growth Rate (2015-2020)
Table Galmed Pharmaceuticals Company Profile
Table Galmed Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
Figure Galmed Pharmaceuticals Production and Growth Rate
Figure Galmed Pharmaceuticals Value ($) Market Share 2015-2020
Table Zydus Cadila Company Profile
Table Zydus Cadila Production, Value, Price, Gross Margin 2015-2020
Figure Zydus Cadila Production and Growth Rate
Figure Zydus Cadila Value ($) Market Share 2015-2020
Table Conatus Pharmaceuticals Company Profile
Table Conatus Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
Figure Conatus Pharmaceuticals Production and Growth Rate
Figure Conatus Pharmaceuticals Value ($) Market Share 2015-2020
Table Gilead Sciences, Inc. Company Profile
Table Gilead Sciences, Inc. Production, Value, Price, Gross Margin 2015-2020
Figure Gilead Sciences, Inc. Production and Growth Rate
Figure Gilead Sciences, Inc. Value ($) Market Share 2015-2020
Table Novo Nordisk Company Profile
Table Novo Nordisk Production, Value, Price, Gross Margin 2015-2020
Figure Novo Nordisk Production and Growth Rate
Figure Novo Nordisk Value ($) Market Share 2015-2020
Table Genfit SA Company Profile
Table Genfit SA Production, Value, Price, Gross Margin 2015-2020
Figure Genfit SA Production and Growth Rate
Figure Genfit SA Value ($) Market Share 2015-2020
Table Intercept Pharmaceuticals, Inc. Company Profile
Table Intercept Pharmaceuticals, Inc. Production, Value, Price, Gross Margin 2015-2020
Figure Intercept Pharmaceuticals, Inc. Production and Growth Rate
Figure Intercept Pharmaceuticals, Inc. Value ($) Market Share 2015-2020
Table Raptor Pharmaceuticals Company Profile
Table Raptor Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
Figure Raptor Pharmaceuticals Production and Growth Rate
Figure Raptor Pharmaceuticals Value ($) Market Share 2015-2020
Table Allergan Plc (Tobira) Company Profile
Table Allergan Plc (Tobira) Production, Value, Price, Gross Margin 2015-2020
Figure Allergan Plc (Tobira) Production and Growth Rate
Figure Allergan Plc (Tobira) Value ($) Market Share 2015-2020
Figure North America Market Consumption and Growth Rate Forecast (2020-2025)
Figure Europe Market Consumption and Growth Rate Forecast (2020-2025)
Figure Asia-Pacific Market Consumption and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Market Consumption and Growth Rate Forecast (2020-2025)
Figure South America Market Consumption and Growth Rate Forecast (2020-2025)
Table Global Nash Drugs Market Forecast Production by Types (2020-2025)
Table Global Nash Drugs Market Forecast Production Share by Types (2020-2025)
Table Global Nash Drugs Market Forecast Value ($) by Types (2020-2025)
Table Global Nash Drugs Market Forecast Value Share by Types (2020-2025)
Table Global Nash Drugs Market Forecast Consumption by Applications (2020-2025)
Table Global Nash Drugs Market Forecast Consumption Share by Applications (2020-2025)
Research Methodology:
Nash Drugs Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|